HDL and Apolipoprotein A1 concentrations as markers of cholesterol efflux in middle-aged women: interaction with smoking
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F12%3A00057939" target="_blank" >RIV/00023001:_____/12:00057939 - isvavai.cz</a>
Result on the web
<a href="http://www.nel.edu/home.htm" target="_blank" >http://www.nel.edu/home.htm</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
HDL and Apolipoprotein A1 concentrations as markers of cholesterol efflux in middle-aged women: interaction with smoking
Original language description
OBJECTIVES: It has been demonstrated that the deleterious effect of smoking on the cardiovascular system is mediated through a decrease in protective HDL cholesterol. In addition, women are more sensitive to the negative effects of smoking, although theexact mechanism underlying this phenomenon is currently unknown. In this study, we evaluated whether smoking habits could modify the association of HDL cholesterol and apolipoprotein A1 (ApoA1) with reverse cholesterol transport (RCT), as measured by cholesterol efflux (CHE), in middle-aged women. DESIGN: The study group consisted of 39 healthy middle-aged women, 21 non-smokers (age 51.8 +/- 2.5 years, BMI 25.1 +/- 2.8 kg/m(2)) and 18 smokers (age 50.5 +/- 3.2 years, BMI 24.8 +/- 3.5 kg/m(2)). In addition to all traditional cardiovascular risk factors, CHE from macrophages, labelled during a 48-hour incubation in a medium containing [C-14] cholesterol, to plasma acceptors in study subjects was established as a marker of reverse choleste
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NT12170" target="_blank" >NT12170: Genetic determination of the nicotine dependence and the efficaccy of the nicotine dependence treatment</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Neuroendocrinology letters
ISSN
0172-780X
e-ISSN
—
Volume of the periodical
33
Issue of the periodical within the volume
suppl. 2
Country of publishing house
SE - SWEDEN
Number of pages
5
Pages from-to
38-42
UT code for WoS article
000312175400008
EID of the result in the Scopus database
—